'Giant pore formation on the surface of cancer cells' We established new type of therapeutic mAbs against malignant lymphomas. Treatment with Anapocosis mAb induced the formation of large pores on the surface of target lymphoma cells within 30 min. The pore diameter is 100 times larger than complements or perforin-formed pores.

'Giant pore formation on the surface of cancer cells' We established new type of therapeutic mAbs against malignant lymphomas. Treatment with Anapocosis mAb induced the formation of large pores on the surface of target lymphoma cells within 30 min. The pore diameter is 100 times larger than complements or perforin-formed pores.

NEWS

March 20, 2024NEW
Video showing humanized 4713 (h4713) monoclonal antibody (mAb) killing malignant lymphoma cells in less than an hour.
March 1, 2021
J-mab was published in Nikkei Biotech.
March 1, 2021
J-mab's English site is renewed !

About Us

Overview Of The Project

Contact Us

to top of page